Gene · 4038
Papers1,660
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,660
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Detection of Antibodies against the Acetylcholine Receptor in Patients with Myasthenia Gravis: A Comparison of Two Enzyme Immunoassays and a Fixed Cell-Based Assay. | J Clin Med | 2023 | 37510896 | PubTator, text mining | PubMed |
| A Rare Presentation of Narcolepsy With Cataplexy After Vaccines in a Genetically Susceptible Elderly Woman: A Case Report. | Cureus | 2023 | 37503483 | PubTator, text mining | PubMed |
| Current understanding of CTLA-4: from mechanism to autoimmune diseases. | Front Immunol | 2023 | 37497212 | PubTator, text mining | PubMed |
| Single-Nucleus Transcriptome Profiling of Dorsolateral Prefrontal Cortex: Mechanistic Roles for Neuronal Gene Expression, Including the 17q21.31 Locus, in PTSD Stress Response. | Am J Psychiatry | 2023 | 37491937 | PubTator, text mining | PubMed |
| WNT-β Catenin Signaling as a Potential Therapeutic Target for Neurodegenerative Diseases: Current Status and Future Perspective. | Diseases | 2023 | 37489441 | PubTator, text mining | PubMed |
| PCDH7 as the key gene related to the co-occurrence of sarcopenia and osteoporosis. | Front Genet | 2023 | 37476411 | PubTator, text mining | PubMed |
| Serum amino acid profiles in patients with myasthenia gravis. | Amino Acids | 2023 | 37474707 | PubTator, text mining | PubMed |
| Cholinergic-estrogen interaction is associated with the effect of education on attenuating cognitive sex differences in a Thai healthy population. | PLoS One | 2023 | 37471329 | PubTator, text mining | PubMed |
| The mechanisms of class 1A PI3K and Wnt/β-catenin coupled signaling in breast cancer. | Biochem Soc Trans | 2023 | 37471270 | PubTator, text mining | PubMed |
| Neurological adverse events associated with PD-1/PD-L1 immune checkpoint inhibitors. | Front Neurosci | 2023 | 37456998 | PubTator, text mining | PubMed |
| Genetic insight into the putative causal proteins and druggable targets of osteoporosis: a large-scale proteome-wide mendelian randomization study. | Front Genet | 2023 | 37448626 | PubTator, text mining | PubMed |
| Difference in symptom manifestation between postmenopausal and premenopausal women in acute uncomplicated cystitis: A multi-institutional pilot study. | Curr Urol | 2023 | 37448620 | PubTator, text mining | PubMed |
Identification and Characterization of the Very-Low-Density Lipoprotein Receptor Gene from Branchiostoma belcheri: Insights into the Origin and Evolution of the Low-Density Lipoprotein Receptor Gene Family. | Animals (Basel) | 2023 | 37443991 | PubTator, text mining | PubMed |
| Lymphoplasmapheresis versus plasma exchange in severe myasthenia gravis: a retrospective cohort study. | Front Neurol | 2023 | 37441608 | PubTator, text mining | PubMed |
| A risk model constructed using 14 N6-methyladenosine-related lncRNAs as a new prognostic marker that correlates with the immunomodulatory effect and drug sensitivity in colorectal cancer. | J Gastrointest Oncol | 2023 | 37435206 | PubTator, text mining | PubMed |
| [Pathogenic Autoantibodies in Myasthenia Gravis]. | Brain Nerve | 2023 | 37431073 | PubTator, text mining | PubMed |
| Circulating miRNAs drive personalized medicine based on subgroup classification in myasthenia gravis patients. | Neurol Sci | 2023 | 37402938 | PubTator, text mining | PubMed |
| Physician- and patient-reported perspectives on myasthenia gravis in Europe: a real-world survey. | Orphanet J Rare Dis | 2023 | 37386469 | PubTator, text mining | PubMed |
| A novel multifunctional radioprotective strategy using P7C3 as a countermeasure against ionizing radiation-induced bone loss. | Bone Res | 2023 | 37385982 | PubTator, text mining | PubMed |
| Human prostate organoid generation and the identification of prostate development drivers using inductive rodent tissues. | Development | 2023 | 37376888 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4038/papers?page=14